COMPARE AND EXAMINE FIBRINOGEN LEVEL IN PATIENTS WITH DIABETES MELLITUS TYPE 2

M. Suljić ,
M. Suljić

General hospital, Novi Pazar Serbia

A. Jovanović
A. Jovanović

Medical faculty Priština , Kosovska Mitrovica , Kosovo*

Published: 01.12.2009.

Volume 37, Issue 2 (2009)

pp. 37-42;

https://doi.org/10.70949/pramed200902292S

Abstract

The middle of last century it was established that the increased value registered fibrinogen in patients with coronary disease, hypertension, peripheral artery disease, patients with diabetes mellitus. Fibrinogen also participate in the earliest stages of atherosclerosis.Task of our research was to compare the level of fibrinogen in patients of type 2 diabetes mellitus without complications, and manifested in patients with apparent chronic complications as well as the correlation of fibrinogen with the parameters of metabolic control. Included 64 respondents, a close age divided into 4 groups: control group, people of type 2 diabetes mellitus without complications, people with microvascular complications, and people with macrovascular complications.The highest average value of fibrinogen in the blood we had in the group with diabetes mellitus without complications (3.47±0.26 g/l) and the lowest mean value in the control group (2.87±0.15 g/l). It is a test of correlation showed a strong correlation with the value of fibrinogen level of development of chronic complications.

Keywords

References

1.
Bruno G. Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis. 125(8):653–7.
2.
Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA. 258:1183–6.
3.
Wilhemsen L, Svardsuss K, Korsan-Bengsten K. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 311:501–5.
4.
Heinrich J, Balleisen L, Schulte H, Assman G, Loo J. Fibrinogen and factor VII in the prediction of coronary risk. In: Results from the PROCAM study in healthy men Arterioscler Thromb. p. 54–9.
5.
Thompson SG, Kienast J, Pyke SD, Haverkate F, Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group N Engl J Med. 332:635–41.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by